Dengue Vaccine

Dengue is considered to be the fastest growing of all mosquito-borne tropical diseases affecting over 2.5 million people worldwide.3 A live-attenuated tetravalent vaccine based on chimeric yellow fever-dengue virus (CYD-TDV) has been found effective in Phase III efficacy studies.4,5 It is expected to be submitted to regulatory groups in early 2015.6


Continue Reading